Press releases

(July 8, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the U.S. launch of its Matrix2™ 360o Detachable Coils, which have been cleared by the U.S. Food and Drug...

(July 7, 2005) -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the second quarter ended June 30, 2005 on Tuesday, July 19, at 11:00...

(July 1, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that a U.S. District Court jury in Delaware found that Johnson & Johnson's (NYSE: JNJ) CYPHER® drug-eluting stent...

(June 27, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it is voluntarily recalling worldwide all Hemashield® VANTAGE™ Vascular Grafts, which are used in peripheral...

(June 24, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a civil settlement agreement with the U.S. Department of Justice regarding the Department's...

(June 21, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that a jury in a patent infringement case in U.S. District Court in Delaware brought by Johnson & Johnson (NYSE: JNJ)...

(June 20, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has completed enrollment in the transitional phase of the world's largest drug-eluting stent registry. The...

(June 14, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has completed the final phase of the acquisition of Rubicon Medical Corporation (OTC BB: RMDC). Boston...

(June 9, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in Goldman Sachs' 25th Annual Healthcare Conference, which is being held June 13 -16 in Dana Point, CA....

(June 9, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that a Dutch court has ruled that Cordis Europa N.V. ("Cordis"), a subsidiary of Johnson & Johnson (NYSE: JNJ),...